PNC Financial Services Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.2K | Buy |
922
+770
| +507% | +$33.6K | ﹤0.01% | 3233 |
|
|
2025
Q1 | $4.16K | Buy |
152
+39
| +35% | +$1.07K | ﹤0.01% | 4130 |
|
|
2024
Q4 | $4.55K | Buy |
113
+100
| +769% | +$4.02K | ﹤0.01% | 4066 |
|
|
2024
Q3 | $615 | Hold |
13
| – | – | ﹤0.01% | 4535 |
|
|
2024
Q2 | $388 | Sell |
13
-29
| -69% | -$866 | ﹤0.01% | 4564 |
|
|
2024
Q1 | $1.69K | Buy |
42
+4
| +11% | +$161 | ﹤0.01% | 4246 |
|
|
2023
Q4 | $967 | Buy |
+38
| New | +$967 | ﹤0.01% | 4324 |
|
|
2021
Q4 | – | Sell |
-17
| Closed | -$1K | – | 4537 |
|
|
2021
Q3 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 4205 |
|